Journal Title：Clinical Reviews In Allergy & Immunology

This journal publishes scholarly reviews and experimental papers that address the state of the art in the management of allergic and immunologic diseases and in particular place newly available data into perspective. Each issue of the journal is devoted to a single theme of critical importance to allergists and immunologists, with the goal of providing a comprehensive treatment of the subject that will benefit a wide readership. Readers will find the journal of value in elucidating the impact of novel data on clinical management against the background of advances such as the development of standardized protocols for allergy skin testing and challenge procedures and improved understanding of cell biology. The ultimate objective is to help improve the care and management of patients with immune-mediated disease.

本期刊發(fā)表學(xué)術(shù)評論和實驗論文，探討過敏和免疫疾病管理的最新進(jìn)展，特別是將新獲得的數(shù)據(jù)放在正確的角度。該期刊的每一期都致力于一個對過敏癥和免疫學(xué)家至關(guān)重要的主題，旨在提供對該主題的全面處理，使廣大讀者受益。讀者會發(fā)現(xiàn)，在諸如制定過敏皮膚測試和激發(fā)程序的標(biāo)準(zhǔn)化方案以及提高對細(xì)胞生物學(xué)的理解等進(jìn)步的背景下，該期刊闡明了新數(shù)據(jù)對臨床管理的影響。最終目標(biāo)是幫助改善免疫介導(dǎo)疾病患者的護(hù)理和管理。

Clinical Reviews In Allergy & Immunology創(chuàng)刊于1983年，由Springer US出版商出版，收稿方向涵蓋醫(yī)學(xué) - 過敏全領(lǐng)域，此刊是該細(xì)分領(lǐng)域中屬于非常不錯的SCI期刊，在行業(yè)細(xì)分領(lǐng)域中學(xué)術(shù)影響力較大，專業(yè)度認(rèn)可很高，所以對原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 較慢,6-12周 ，影響因子指數(shù)8.4，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。